0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
Hugh Y. Rienhoff, Jr.
5 members
Dyno Therapeutics
4 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies